Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis

Shumsky,Alexandr; Bilan,Evgeniy; Sanz,Eduardo; Petrovskiy,Fedor

doi:10.3892/mco.2019.1809

April-2019 Volume 10 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2019 Volume 10 Issue 4

Full Size Image

Article Open Access

Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis

Authors:
- Alexandr Shumsky
- Evgeniy Bilan
- Eduardo Sanz
- Fedor Petrovskiy
View Affiliations / Copyright

Affiliations: Medical Scientific Centre of Professor Shumsky, 443303 Samara, Russia, Khanty-Mansiysk Regional Hospital, 628011 Khanty-Mansiysk, Russia, Catalysis S.L., 28016 Madrid, Spain, Khanty-Mansiysk State Medical Academy, 628011 Khanty-Mansiysk, Russia

Copyright: © Shumsky et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Pages: 463-468
|
Published online on: February 14, 2019

https://doi.org/10.3892/mco.2019.1809
Expand metrics +

Abstract

Oral mucositis (OM) is a common and potentially dangerous complication of anticancer treatment. Since there are only few therapeutic options for OM, there is a need to identify novel approaches to its management and prevention. The aim of the present study was to evaluate the efficacy of Oncoxin (ONCX), a nutritional supplement that contains microelements, vitamins, amino acids and certain biologically active substances of natural origin, in cancer patients who receive chemotherapy, radiotherapy or a combination of the two. A total of 15 male and female patients (aged 45‑75 years) with malignant neoplasms, who had been prescribed radiotherapy, chemotherapy or a combination of the two, with an Eastern Cooperative Oncology Group performance status score ≤3, and grade 2‑3 OM based on the World Health Organization (WHO) Oral Toxicity Scale, were enrolled in a 20‑day study; 10 patients were in the ONCX group and 5 served as controls. The patients were allowed to use any anticancer treatment and any type of OM care. In addition to their current treatment, patients in the ONCX group used 25 ml of the ONCX nutritional supplement twice daily for 20 days. The mean WHO Oral Toxicity Scale grade decreased by 41% in the ONCX group after ~7 days from the beginning of the study compared with minimal change in the control group. At the end of the study, the difference was even more prominent, with a 73 and 20% decrease from baseline in the ONCX and control groups, respectively (P<0.001). During the entire trial period, patients in the ONCX group were able to eat normally during 65% of the time, in contrast to only 29% in the control group (P=0.04). There were no statistically significant changes in absolute body mass, or in the number of days with normal appetite. This was a pilot study aiming to show the benefits of the ONCX nutritional supplement in OM, and the results demonstrated that ONCX rapidly improved the symptoms of OM and helped to maintain normal eating habits in patients undergoing cancer treatment.

View Figures

View References

1	Shumsky AV: Pathology of oral cavity induced by chemotherapy and radiotherapy in oncology patients. Oncology for Dentists. Stomatology for Oncologists. Vse pravilno: Moscow: pp. 234–246. 2016
2	Lalla RV, Sonis ST and Peterson DE: Management of oral mucositis in patients who have cancer. Dent Clin North Am. 5261–77. (viii)2008. View Article : Google Scholar : PubMed/NCBI
3	Campos MI, Campos CN, Aarestrup FM and Aarestrup BJ: Oral mucositis in cancer treatment: Natural history, prevention and treatment. Mol Clin Oncol. 2:337–340. 2014. View Article : Google Scholar : PubMed/NCBI
4	Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, Fraser CJ and Scarffe JH: Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol. 110:292–299. 2000. View Article : Google Scholar : PubMed/NCBI
5	Al-Mahtab M, Akbar SM, Khan MS and Rahman S: Increased survival of patients with end-stage hepatocellular carcinoma due to intake of ONCOXIN^®, a dietary supplement. Indian J Cancer. 52:443–446. 2015. View Article : Google Scholar : PubMed/NCBI
6	Dzhugashvili M, Pokrovsky VS and Snegovoy AV: Novel approaches for the correction of micronutrient deficiency in patients with malignant tumors. Malignant Tumours. 2:55–65. 2016.
7	Zhao H, Zhu W, Xie P, Li H, Zhang X, Sun X, Yu J and Xing L: A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. Radiother Oncol. 110:132–136. 2014. View Article : Google Scholar : PubMed/NCBI
8	Zhao H, Xie P, Li X, Zhu W, Sun X, Sun X, Chen X, Xing L and Yu J: A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer. Radiother Oncol. 114:351–356. 2015. View Article : Google Scholar : PubMed/NCBI
9	Kantor ED, Lampe JW, Navarro SL, Song X, Milne GL and White E: Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation. J Altern Complement Med. 20:479–485. 2014. View Article : Google Scholar : PubMed/NCBI
10	Bak YK, Lampe JW and Sung MK: Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis. J Gastroenterol Hepatol. 29:957–963. 2014. View Article : Google Scholar : PubMed/NCBI
11	Prasad AS, Beck FWJ, Bao B, Fitzgerald JT, Snell DC, Steinberg JD and Cardozo LJ: Zinc supplementation decreases incidence of infections in the elderly: Effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 85:837–844. 2007. View Article : Google Scholar : PubMed/NCBI
12	Akimoto M, Kimura M, Sawano A, Iwasaki H, Nakajima Y, Matano S and Kasai M: Prevention of cancer chemotherapeutic agent-induced toxicity in postoperative breast cancer patients with glycyrrhizin (SNMC). Gan No Rinsho. 32:869–872. 1986.(In Japanese). PubMed/NCBI
13	Yan Y, Mo Y and Zhang D: Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors. Zhonghua Gan Zang Bing Za Zhi. 23:204–208. 2015.(In Chinese). PubMed/NCBI
14	Consolo LZ, Melnikov P, Cônsolo FZ, Nascimento VA and Pontes JC: Zinc supplementation in children and adolescents with acute leukemia. Eur J Clin Nutr. 67:1056–1059. 2013. View Article : Google Scholar : PubMed/NCBI
15	Ames BN: DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 475:7–20. 2001. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles